Health Experts Highlight Progress in HIV Treatment in Nigeria
Health professionals assured Nigerians on Friday that advancements in science and technology have transformed a human immunodeficiency virus (HIV) diagnosis from a death sentence to a manageable condition. This message came during the 25th anniversary celebrations of the APIN Public Health Initiative in Abuja, where participants reflected on Nigeria’s significant strides in combating HIV since the early 2000s.
Evolution of HIV Treatment in Nigeria
Professor Prosper Okonkwo, Chief Executive Officer of APIN, emphasized that years of public health investment and access to treatment have shifted perceptions about HIV. In the early 2000s, many individuals diagnosed with HIV faced grim realities, as antiretroviral drugs were scarce and the concept of living with the virus was almost unthinkable.
A Dark History of the HIV Pandemic
Okonkwo recounted a troubling history, depicting a nation grappling with loss and fear. “In 2000, people living with HIV in Nigeria felt as though they had received a death sentence. There was no path to achieving an undetectable viral load, and the notion of a healthy marriage seemed impossible,” he noted. This tragic backdrop was compounded by a deafening silence surrounding the epidemic, as many tried to conceal their status while confronting mortality.
Positive Changes in HIV Management
Today, Okonkwo reported, the landscape has significantly improved. Those living with HIV are now able to suppress the virus and enjoy healthy, fulfilling lives. “They can have children free from the virus, pursue careers, and build families without being defined by their status,” he stated, underscoring that these advances are a result of collaborative efforts among governments, healthcare providers, and development partners.
APIN’s Role in Restructuring Healthcare
Over its 25 years of operation, APIN has reformed service delivery within Nigeria’s health system by training healthcare professionals, strengthening laboratory capacities, and enhancing access to treatment across urban and rural locales. This comprehensive approach has played a vital role in improving outcomes for those living with HIV.
Current Challenges in Funding and Treatment Access
However, Uche Okezie, APIN’s Director of Strategic Information, highlighted ongoing challenges posed by global funding cuts, which limit the number of patients receiving antiretroviral treatment. Despite these hurdles, he conveyed optimism as the National Aids Control Authority actively seeks solutions. “Currently, over 1.6 million people are on antiretroviral medication, with about 314,804 patients under APIN’s care,” he explained, noting that significant numbers now have suppressed viral loads.
Impact on Families and Children
Dr. Mikhail Obadje, APIN’s Deputy Director for Strategic Information, reported substantial achievements in maternal and pediatric HIV care. As of March 2026, APIN has supported more than 83,000 pregnant women and children in states hit hardest by the epidemic, including Oyo, Ogun, Ondo, Plateau, and Benue. “Data indicates that 60,704 HIV-positive pregnant women began treatment, and 22,585 children received antiretroviral therapy as a result of testing positive for the virus,” he revealed, emphasizing the initiative’s role in preventing mother-to-child transmission.
Ongoing Research and Expansion Efforts
Furthermore, the organization has expanded its reach over the years, testing nearly three million pregnant women, leading to significant treatment advancements. “Since 2016, we have tested over 2.5 million children and adolescents for HIV, successfully identifying and treating 22,585 cases,” Obadje concluded. Currently, APIN operates research labs across five states and maintains a presence in a total of 30 states, a testament to its enduring commitment to combating HIV in Nigeria.
